News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,905 Results
Type
Article (14914)
Company Profile (299)
Press Release (266686)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79844)
Career Advice (163)
Deals (13337)
Drug Delivery (39)
Drug Development (50708)
Employer Resources (31)
FDA (5839)
Job Trends (5170)
News (145098)
Policy (10072)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (920)
Accelerated approval (20)
Adcomms (14)
Allergies (85)
Alliances (21763)
ALS (126)
Alzheimer's disease (1035)
Antibody-drug conjugate (ADC) (244)
Approvals (6035)
Artificial intelligence (267)
Autoimmune disease (119)
Automation (9)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (46)
Breast cancer (348)
Cancer (3163)
Cardiovascular disease (239)
Career advice (148)
Career pathing (8)
CAR-T (224)
CDC (5)
Cell therapy (577)
Cervical cancer (14)
Clinical research (43726)
Collaboration (1168)
Company closure (2)
Compensation (604)
Complete response letters (42)
COVID-19 (1101)
CRISPR (88)
C-suite (568)
Cystic fibrosis (112)
Data (4362)
Denatured (15)
Depression (93)
Diabetes (256)
Diagnostics (1383)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (196)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (218)
Earnings (31688)
Editorial (27)
Employer branding (4)
Employer resources (29)
Events (51712)
Executive appointments (629)
FDA (7607)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (991)
Gene editing (185)
Generative AI (22)
Gene therapy (497)
GLP-1 (507)
Government (1149)
Grass and pollen (3)
Guidances (166)
Healthcare (6612)
HIV (18)
Huntington's disease (44)
IgA nephropathy (75)
Immunology and inflammation (194)
Immuno-oncology (43)
Indications (71)
Infectious disease (1211)
Inflammatory bowel disease (158)
Inflation Reduction Act (10)
Influenza (40)
Intellectual property (169)
Interviews (18)
IPO (7346)
IRA (13)
Job creations (867)
Job search strategy (130)
JPM (40)
Kidney cancer (9)
Labor market (24)
Layoffs (244)
Leadership (10)
Legal (1401)
Liver cancer (41)
Longevity (11)
Lung cancer (425)
Lymphoma (251)
Machine learning (24)
Management (7)
Manufacturing (380)
MASH (132)
Medical device (2666)
Medtech (2675)
Mergers & acquisitions (6623)
Metabolic disorders (733)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (234)
Neuropsychiatric disorders (70)
Neuroscience (1967)
Neurotech (1)
NextGen: Class of 2026 (2034)
Non-profit (867)
Now hiring (31)
Obesity (333)
Opinion (125)
Ovarian cancer (132)
Pain (103)
Pancreatic cancer (165)
Parkinson's disease (233)
Partnered (12)
Patents (306)
Patient recruitment (345)
Peanut (44)
People (26693)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15493)
Phase 2 (20317)
Phase 3 (12832)
Pipeline (3360)
Policy (91)
Postmarket research (853)
Preclinical (6541)
Press Release (30)
Prostate cancer (147)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (661)
Real estate (1449)
Recruiting (12)
Regulatory (9925)
Reports (20)
Research institute (973)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (125)
Series A (184)
Series B (140)
Service/supplier (1)
Sickle cell disease (78)
Special edition (19)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (341)
Venture capital (69)
Weight loss (174)
Women's health (26)
Worklife (2)
Date
Today (9)
Last 7 days (275)
Last 30 days (1119)
Last 365 days (17770)
2026 (1982)
2025 (18098)
2024 (20543)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23358)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11840)
2015 (14352)
2014 (10394)
2013 (7485)
2012 (7533)
2011 (7614)
2010 (7428)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18276)
Australia (3114)
California (7144)
Canada (1859)
China (784)
Colorado (249)
Connecticut (255)
Delaware (237)
Europe (39225)
Florida (913)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (398)
India (36)
Indiana (162)
Iowa (8)
Japan (228)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (740)
Massachusetts (5630)
Michigan (110)
Minnesota (250)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1659)
New Mexico (13)
New York (1777)
North Carolina (837)
North Dakota (6)
Northern California (3518)
Ohio (180)
Oklahoma (11)
Oregon (24)
Pennsylvania (1287)
Puerto Rico (9)
Rhode Island (26)
South America (215)
South Carolina (9)
Southern California (2832)
Tennessee (40)
Texas (921)
United States (23544)
Utah (97)
Virginia (137)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (46)
281,905 Results for "entrada therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Entrada Therapeutics to Present at Upcoming Investor Conferences - February 4, 2026
February 4, 2026
·
1 min read
Press Releases
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
January 8, 2026
·
11 min read
Press Releases
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025
·
1 min read
Press Releases
Entrada Therapeutics Reports Third Quarter 2025 Financial Results
November 6, 2025
·
10 min read
Press Releases
Entrada Therapeutics to Present at Upcoming Investor Conferences - October 28, 2025
October 28, 2025
·
1 min read
Press Releases
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 4, 2025
December 5, 2025
·
2 min read
Press Releases
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
September 8, 2025
·
4 min read
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Entrada Therapeutics Reports Second Quarter 2025 Financial Results
August 6, 2025
·
11 min read
Press Releases
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 2, 2025
September 3, 2025
·
2 min read
1 of 28,191
Next
